Genital Herpes Treatment Market sale is forecast to exceed the valuation of US$ 2881.8 Million by the end of 2031
The global Genital Herpes Treatment Market is predicted to grow rapidly and surpass US$ 2881.8 Mn by the end of 2031, per the report’s market forecasts. During the projected period of 2021–2031, the market is anticipated to see a CAGR of 4.5%.
Genital herpes is a normal sexually transmitted disease. The prevalence of health issues is increasing globally along with population density in various places. With the rise in disease prevalence, it is projected that the markets for therapies would grow dramatically.
There is a market for drugs like Acyclovir, Valacyclovir, and Famciclovir to treat STDs like genital herpes. HSV-1 and HSV-2 are among the signs and symptoms of genital herpes.
Get Sample PDF Brochure:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1390
The increase in government spending on the healthcare sector is the main factor fueling market expansion. Many nations are putting a lot of effort into preventing infectious diseases, which benefits the market for herpes medications and increases demand from local governments and third-party payers.
Global Genital Herpes Treatment Market: Trends and Opportunities
Genital herpes therapies may have new market potential. Globally, the prevalence of herpes infection is rising, creating a market opportunity for diagnostic and treatment goods.
According to WHO estimates, 67% of the world’s population—or over 3.7 billion people—had HSV-1 infection in 2016. This suggests that the market for treating HSV disease will significantly grow over the course of the projection period. In a similar vein, 491 million people worldwide (almost 13% of those under 50) had HSV-2 infection as of 2016.
Also, the companies are aiming to provide affordable treatment options. New immunisations provide complete protection against a variety of HSV1 and HSV2 strains. Businesses are speeding up their research and development efforts to help cure and prevent genital herpes diseases. The majority of firms are focusing on the approval and introduction of generic drugs in developing countries in order to give accessible treatments for genital herpes.
Ask An Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-1390
Global Genital Herpes Treatment Market: Key Highlights from the Segmental Analysis
MEA is expected to come up as the most lucrative region in the industry. With the rise in sexually transmitted diseases in the region, the demand for genital herpes treatment is also expected to rise.
Regional analysis shows that MEA will witness a robust CAGR of 5.2% during the forecast period in the global genital herpes treatment market. Based on the route of administration oral is the main segment, with the highest growth rate and highest market share in the global genital herpes treatment market.
Amongst various distribution channels, retail pharmacies hold the highest market size, but the segment lags behind in terms of growth rate. With the growth of online marketing and e-commerce, online pharmacies is the fastest growing segment which is expected to register a growth rate of 5.4% during the forecast period.
Global Genital Herpes Treatment Market: Top Companies
Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc., etc.
Ask for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-1390
Key Segments Covered in Genital herpes treatment Market Study
Drug Type:
- Acyclovir
- Valacyclovir
- Famciclovir
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Route of Administration:
- Oral
- Topical
- Injectable
Indication:
- HSV-1
- HSV-2
Key Regions/Countries Covered:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Ex. Japan (APEJ)
- Japan
- Middle East & Africa
Use promo code >> FMITODAY to get flat 20% discount
More Related Reports:
Smart Pill Technologies Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
Editor Details
-
Company:
- MARKITWIRED
- Website:
